CD52 and neoplasm: We also found that liver-derived CD52− NK cells exhibited 4-fold greater cytotoxicity toward K562 tumor cells and produced 20-fold more IFN-γ than liver-derived CD52+ NK cells when activated with IL-2 (Fig 4).